NCT06240767View on ClinicalTrials.gov

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Solid Tumor, AdultAdvanced Cancer
Interventions
BIOLOGICAL

Granulocyte infusion

The number of single granulocytes per infusion was 2.0-5.0×10\^10, with an interval of 2±1 day and 5 continuous infusions.

Trial Locations (1)

214043

RECRUITING

Wuxi People's Hospital, Wuxi

All Listed Sponsors
lead

Wuxi People's Hospital

OTHER